Nokia Corporation - Managers' transactions (Heard)

Nokia Corporation
Managers’ transactions
14 August 2025 at 15:00 EEST

Nokia Corporation - Managers' transactions (Heard)

Transaction notification under Article 19 of EU Market Abuse Regulation.
____________________________________________
Person subject to the notification requirement
Name: Heard, David
Position: Other senior manager

Issuer: Nokia Corporation
LEI: 549300A0JPRWG1KI7U06
Notification type: INITIAL NOTIFICATION
Reference number: 118931/5/4
____________________________________________

Transaction date: 2025-08-12
Venue: NEW YORK STOCK EXCHANGE (XNYS)
Instrument type: SHARE
ISIN: US6549022043
Nature of the transaction: ACQUISITION

Transaction details
(1): Volume: 816 Unit price: 4.09417 USD

Aggregated transactions
(1): Volume: 816 Volume weighted average price: 4.09417 USD

About Nokia
At Nokia, we create technology that helps the world act together.

As a B2B technology innovation leader, we are pioneering networks that sense, think and act by leveraging our work across mobile, fixed and cloud networks. In addition, we create value with intellectual property and long-term research, led by the award-winning Nokia Bell Labs, which is celebrating 100 years of innovation.

With truly open architectures that seamlessly integrate into any ecosystem, our high-performance networks create new opportunities for monetization and scale. Service providers, enterprises and partners worldwide trust Nokia to deliver secure, reliable and sustainable networks today – and work with us to create the digital services and applications of the future.

Inquiries:

Nokia Communications
Phone: +358 10 448 4900
Email: [email protected]
Maria Vaismaa, Global Head of External Communications

Nokia
Investor Relations
Phone: +358 931 580 507
Email: [email protected]

You May Also Be Interested In

• Regina, Saskatchewan hosts Canada’s only Track and Field championship for U16 and U18
• Solana Price Prediction: GSOL Starts Cash Staking Payouts as AlphaPepe’s Stage 20 Demand Builds the Scarcity Trade
• Tyros Biopharma Accelerates Expansion of Women’s Health Portfolio With Four New Product Introductions in 2026